Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-23

Clinical Trial Update: Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

View source ↗

Summary

This completed clinical trial assessed the efficacy and safety of conventional immunosuppressant therapies in elderly patients with neuromyelitis optica spectru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Samsung Medical Center | Conditions: Neuromyelitis Optica Spectrum Disorder (NMOSD) | Status: COMPLETED